The Revenge Of Obamacare Just Tanked Merck And Other Pharmaceutical Manufacturers

Shares of Merck & Co. Inc. (MRK) are currently down $0.58 or 1.55% to $36.92 a share as Obama unveils his latest healthcare initiative.

One damming factor of the President’s agenda is a $10B hike in additional fees on drugmakers.

Shares of Glaxo Smith Kline (GSK) are also falling, currently down $0.83 or 2.2% to $37.42 a share. AmerisourceBergen Corp. (ABC) is down $0.17 or 0.66% to $27.95 a share.

drug companies feb21

NOW WATCH: Money & Markets videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at research.businessinsider.com.au.